Tag: chronic obstructive pulmonary disease

Understanding Chronic Obstructive Pulmonary Disease (COPD): A comprehensive guide

businessnewstoday- March 10, 2024

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that encompasses emphysema and chronic bronchitis, often leading to severe respiratory issues. Affecting approximately ... Read More

Lupin, Mark Cuban’s Cost Plus Drugs and COPD Foundation boost COPD treatment access

businessnewstoday- September 6, 2023

In a significant healthcare development, global pharmaceutical giant Lupin Limited (Lupin) has entered into a groundbreaking collaboration with Mark Cuban Cost Plus Drug Company (Cost ... Read More

Lupin gets Health Canada approval for generic Spiriva for COPD treatment

businessnewstoday- May 27, 2023

Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium ... Read More

Lupin to acquire rights to Brovana and Xopenex HFA for $75m

businessnewstoday- October 20, 2022

Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) ... Read More

Lupin bags UK approval for Lutio inhalation product for COPD treatment

pallavi123- August 26, 2022

Lupin through its subsidiary — Lupin Healthcare (UK) has secured approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Lutio, a generic ... Read More

Zydus gets FDA approval for COPD drug Roflumilast Tablets

pallavi123- February 14, 2022

Zydus Group said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) to market Roflumilast Tablets ... Read More

Lupin Limited gets approval for Luforbec 100/6 µg pMDI in UK

pallavi123- June 20, 2021

Lupin Limited said that its subsidiary Lupin Healthcare (UK) has secured approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for Luforbec (beclometasone dipropionate/formoterol ... Read More

Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment

pallavi123- June 15, 2021

Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI), for the treatment of chronic obstructive ... Read More

Lupin Limited launches generic of Arformoterol Tartrate in US

pallavi123- June 4, 2021

Lupin Limited said that it has launched the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg /2 mL, unit-dose vials, of Sunovion ... Read More